Rua Life Sciences PLC
LSE:RUA
Cash Flow Statement
Cash Flow Statement
Rua Life Sciences PLC
| Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Change in Working Capital |
(0)
|
(0)
|
0
|
1
|
0
|
0
|
(0)
|
0
|
|
| Cash from Operating Activities |
(2)
N/A
|
(2)
-20%
|
(2)
+27%
|
(1)
+33%
|
(2)
-37%
|
(1)
+15%
|
(1)
+49%
|
(0)
+67%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
-32%
|
(1)
+33%
|
(0)
+22%
|
(0)
+8%
|
(0)
+81%
|
0
N/A
|
0
-54%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
6
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
6
N/A
|
(0)
N/A
|
0
N/A
|
0
+76%
|
(0)
N/A
|
4
N/A
|
4
-1%
|
(0)
N/A
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
4
N/A
|
(3)
N/A
|
(2)
+32%
|
(1)
+34%
|
(2)
-37%
|
2
N/A
|
3
+34%
|
(0)
N/A
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(3)
N/A
|
(3)
-22%
|
(2)
+29%
|
(2)
+31%
|
(2)
-23%
|
(1)
+30%
|
(1)
+48%
|
(0)
+61%
|
|